1Maxwell GL,Risinger JI,Gumbs C,et al.Mutations of the PTEN tumor suppressor gene in endometrial hyperplasias[].Cancer Research.1998
2Szuhai K,Sandhaus E,Kolkman-Uljee SM,et al.A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon Polymerase chain reaction[].American Journal of Pathology.2001
3Catasus L,Machin P,Matias-Guiu X,et al.Microsatellite instability in endometrial carcinomas: clinicopathologic correlation in a series of 42 cases[].Human Pathology.1998
4Soslow RA,Pirog E,Isacson C.Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis[].The American Journal of Surgical Pathology.2000
5Ambros RA,Sherman ME,Zahn CM,et al.Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation[].Human Pathology.1995
6Wheeler DT,Bell KA,Kurman RJ,et al.Minimal uterine serous carcinoma.diagnosis and clinicopathologic corrlation[].The American Journal of Surgical Pathology.2000
7Jemal A,Thomas A,Murray T.Cancer statistics, 2002[].CA A Cancer Journal for Clinicians.2002
8Levine RL,Cargile CB,Blazes MS,et al.PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma[].Cancer Research.1998
9Ambros RA,Ross JS,Kallabury BV,et al.P53 gene status in endometrial carcinomas showing diffuse positivity for p53 protein by immunohistochemical analysis[].Modern Pathology.1995
4Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009.CA Cancer J Clin,2009,59(4):225-249.
5Bansal N,Yendluri V,Wenham RM.The molecular biology of endometrial cancers and the implications for pathogenesis,classification,and targeted therapies.Cancer Control,2009,16(1):8-13.
6Oda K,Stokne D,Taketani Y,et al.High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma.Cancer Res,2005,65 (23):10669-10673.
7Catasus L,Gallardo A,Cuatrecasas M,et al.Concomitant PI3KAKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.Mod Pathol,2009,22 (4):522-529.
8Catasus L,Gallardo A,Cuatrecasas M,et al.PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.Mod Pathol,2008,21 (2):131-139.
9Catasus L,D’Angelo E,Pons C,et al.Expression profiling of 22genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations.Mod Pathol,2010,23(5):694-702.
10Konstantinova D,Kaneva R,Dimitrov R,et al.Rare mutations in the PIK3CA gene contribute to aggressive endometrial cancer.DNA Cell Biol,2010,29(2):65-70.
